Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock
2023 · Annals of Intensive Care · 19 citations
https://doi.org/10.1186/s13613-023-01227-5
D
Daniel E. Leisman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
2.5K
Citations
19
h-index
24
i10-index
Daniel E. Leisman is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Sepsis Diagnosis and Treatment & Hemodynamic Monitoring and Therapy & Respiratory Support and Mechanisms. The author has an h-index of 19, co-authored 57 publications.
ORCID: 0000-0001-9670-9425Papers by this author
worksM1 cholinergic signaling in the brain modulates cytokine levels and splenic cell sub-phenotypes following cecal ligation and puncture
2024 · Molecular Medicine · 6 citations
https://doi.org/10.1186/s10020-024-00787-x
An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock
2025 · Critical Care · 6 citations
https://doi.org/10.1186/s13054-025-05311-z
Reply to Akin <i>et al</i> .
2022 · American Journal of Respiratory and Critical Care Medicine · 0 citations
https://doi.org/10.1164/rccm.202202-0292le
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat